BR1100108A - Agonista receptor como 5-ht1 para administração retal - Google Patents

Agonista receptor como 5-ht1 para administração retal

Info

Publication number
BR1100108A
BR1100108A BR1100108-9A BR1100108A BR1100108A BR 1100108 A BR1100108 A BR 1100108A BR 1100108 A BR1100108 A BR 1100108A BR 1100108 A BR1100108 A BR 1100108A
Authority
BR
Brazil
Prior art keywords
pct
receptor agonist
rectal administration
sec
date
Prior art date
Application number
BR1100108-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Original Assignee
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nadine Merlet, Isabelle Richard, Isabelle Thielemans filed Critical Nadine Merlet
Publication of BR1100108A publication Critical patent/BR1100108A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR1100108-9A 1992-05-07 1996-12-24 Agonista receptor como 5-ht1 para administração retal BR1100108A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (1)

Publication Number Publication Date
BR1100108A true BR1100108A (pt) 1999-12-07

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100108-9A BR1100108A (pt) 1992-05-07 1996-12-24 Agonista receptor como 5-ht1 para administração retal

Country Status (33)

Country Link
US (1) US5705506A (enExample)
EP (1) EP0639072B1 (enExample)
JP (1) JPH07506570A (enExample)
KR (1) KR100253111B1 (enExample)
AT (1) ATE163850T1 (enExample)
AU (1) AU670083B2 (enExample)
BE (1) BE1007024A5 (enExample)
BG (1) BG62120B1 (enExample)
BR (1) BR1100108A (enExample)
CA (1) CA2135179C (enExample)
CH (1) CH685920A5 (enExample)
CY (1) CY2039B1 (enExample)
CZ (1) CZ283512B6 (enExample)
DE (1) DE69317418T2 (enExample)
ES (1) ES2113533T3 (enExample)
FR (1) FR2690847B1 (enExample)
GB (2) GB9209882D0 (enExample)
GR (1) GR3026584T3 (enExample)
HK (1) HK95697A (enExample)
HU (2) HU227338B1 (enExample)
IE (1) IE75203B1 (enExample)
IL (1) IL105468A (enExample)
IT (1) IT1261471B (enExample)
NO (1) NO306700B1 (enExample)
NZ (1) NZ252132A (enExample)
OA (1) OA10109A (enExample)
RO (1) RO112993B1 (enExample)
RU (1) RU2118527C1 (enExample)
SG (1) SG46649A1 (enExample)
TW (1) TW231970B (enExample)
UA (1) UA37206C2 (enExample)
WO (1) WO1993021916A1 (enExample)
ZA (1) ZA933178B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (en) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
ID27825A (id) * 1998-03-26 2001-04-26 Fujisawa Pharmaceutical Co Sediaan lepas lambat
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
JP2010522135A (ja) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
CA2813648C (en) 2010-10-15 2019-06-25 Concit Pharma Aps Combinations of serotonin receptor agonists for treatment of movement disorders
CA2870123C (en) 2012-04-18 2021-02-23 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
KR102443161B1 (ko) 2016-07-11 2022-09-14 콘테라 파르마 에이/에스 아침 운동 불능을 치료하기 위한 박동성 약물 전달 시스템

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
NZ197998A (en) * 1980-08-12 1985-08-16 Glaxo Group Ltd 5-amino(methyl)-1h-indol-3-ylalkaneamines
GR79215B (enExample) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
IT1181741B (it) * 1984-12-04 1987-09-30 Glaxo Group Ltd Derivati di indolo,procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
KR0131327B1 (en) * 1987-08-13 1998-04-17 Glaxo Group Ltd Indole derivatives
US5399574A (en) * 1990-06-07 1995-03-21 Burroughs Wellcome Co. Indolyl tetrahydropyridines for treating migraine

Also Published As

Publication number Publication date
RU2118527C1 (ru) 1998-09-10
OA10109A (en) 1996-12-18
GB9209882D0 (en) 1992-06-24
CH685920A5 (fr) 1995-11-15
HK95697A (en) 1997-08-08
CY2039B1 (en) 1998-04-30
NO944214L (no) 1994-11-07
IE75203B1 (en) 1997-08-27
IL105468A (en) 1998-09-24
TW231970B (enExample) 1994-10-11
DE69317418T2 (de) 1998-07-30
GB2266665A (en) 1993-11-10
DE69317418D1 (de) 1998-04-16
SG46649A1 (en) 1998-02-20
HU211638A9 (en) 1995-12-28
WO1993021916A1 (en) 1993-11-11
KR100253111B1 (en) 2000-07-01
ZA933178B (en) 1994-01-10
RO112993B1 (ro) 1998-03-30
BE1007024A5 (fr) 1995-02-21
IE930339A1 (en) 1993-11-17
NZ252132A (en) 1996-09-25
IT1261471B (it) 1996-05-23
GR3026584T3 (en) 1998-07-31
EP0639072B1 (en) 1998-03-11
NO944214D0 (no) 1994-11-04
FR2690847A1 (fr) 1993-11-12
JPH07506570A (ja) 1995-07-20
CA2135179A1 (en) 1993-11-11
IL105468A0 (en) 1993-08-18
FR2690847B1 (fr) 1995-06-09
CA2135179C (en) 2000-12-05
BG99167A (bg) 1995-06-30
CZ283512B6 (cs) 1998-04-15
AU670083B2 (en) 1996-07-04
NO306700B1 (no) 1999-12-13
BG62120B1 (bg) 1999-03-31
US5705506A (en) 1998-01-06
HU227338B1 (en) 2011-04-28
EP0639072A1 (en) 1995-02-22
GB2266665B (en) 1996-05-22
ITRM930286A1 (it) 1994-11-06
UA37206C2 (uk) 2001-05-15
ATE163850T1 (de) 1998-03-15
ITRM930286A0 (it) 1993-05-06
HUT71418A (en) 1995-11-28
ES2113533T3 (es) 1998-05-01
AU4064093A (en) 1993-11-29
CZ272394A3 (en) 1995-10-18
GB9309209D0 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
BR1100108A (pt) Agonista receptor como 5-ht1 para administração retal
BG105534A (en) 5ht1 means and method for the treatment of migraine
PL356252A1 (en) Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
YU2603A (sh) Nova kombinacija (5ht2) agonista i (5ht6) antagonista serotonina kao farmaceutska kombinacija
MX9702865A (es) Agentes estrogenicos.
EA200100870A1 (ru) Композиции-ингибиторы циклооксигеназы-2 с быстро наступающим терапевтическим действием
NO20052019L (no) Blanding for a inhibere sekresjon av magesyre
PT1011632E (pt) Composicao farmaceutica para o tratamento de dismenorreia e parto prematuro
KR950010890A (ko) 폐경기 증후군의 치료방법
NO990912L (no) Terapeutiske kombinasjoner av PAR-antagonister og RXR-agonister og bruken derav
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
BR9910329A (pt) Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
BR0306147A (pt) Uso de um composto ou combinação de compostos tendo atividade agonìstica de receptor de dopamina-d2 parcial e atividade inibidora de reabsorção da serotonina e/ou noradrenalina, método para a preparação de uma composição, e, composição
DK0485431T3 (da) Partielle agonister for det strychnin-ufølsomme glycin-modulations-site i N-methyl-D-aspartat-receptorkomplekset som neurofarmakologiske midler
ES2123499T3 (es) Metodos y composiciones para tratamiento de infecciones virales.
ES2156444T3 (es) Nuevos compuestos.
HUP0004900A2 (hu) Mozgászavarok kezelésére szolgáló, hatóanyagként NMDA-receptor antagonista hatású piperidinszármazékokat tartalmazó gyógyszerkészítmények
FI950209A0 (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
DE69406406D1 (de) Derivate von n,n,n',n'-tetrasubstituierten 1,2-ethylendiamin-verbindungen
BR0005319A (pt) Tratamento combinado para depressão e ansiedade
DK0648117T3 (da) Lægemiddel til at forebygge udvikling af tolerance ved behandling med benzodiazepin-receptor-bindende aktive forbindelser
ATE162946T1 (de) Pharmazeutische zusammensetzungen enthaltend contignasterol-verbindungen
ATE74505T1 (de) Schmerzpraeparat.
SE9501773D0 (sv) New use
ECSP972347A (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas

Legal Events

Date Code Title Description
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96